Raymond James & Associates’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-43,718
| Closed | -$5K | – | 3601 |
|
|
2018
Q4 | $5K | Sell |
43,718
-93,035
| -68% | -$10.6K | ﹤0.01% | 3419 |
|
|
2018
Q3 | $232K | Sell |
136,753
-7,490
| -5% | -$12.7K | ﹤0.01% | 3186 |
|
|
2018
Q2 | $251K | Sell |
144,243
-1,000
| -0.7% | -$1.74K | ﹤0.01% | 3110 |
|
|
2018
Q1 | $266K | Buy |
145,243
+17,000
| +13% | +$31.1K | ﹤0.01% | 2949 |
|
|
2017
Q4 | $286K | Buy |
128,243
+7,300
| +6% | +$16.3K | ﹤0.01% | 2851 |
|
|
2017
Q3 | $351K | Buy |
120,943
+94,000
| +349% | +$273K | ﹤0.01% | 2674 |
|
|
2017
Q2 | $120K | Sell |
26,943
-39,299
| -59% | -$175K | ﹤0.01% | 3054 |
|
|
2017
Q1 | $309K | Buy |
66,242
+4,627
| +8% | +$21.6K | ﹤0.01% | 2673 |
|
|
2016
Q4 | $375K | Buy |
61,615
+13,116
| +27% | +$79.8K | ﹤0.01% | 2499 |
|
|
2016
Q3 | $267K | Buy |
+48,499
| New | +$267K | ﹤0.01% | 2682 |
|